Sector Update: Health Care

Health care stocks were mixed late Friday afternoon with the NYSE Health Care Index fractionally lower and the Health Care Select Sector SPDR Fund (XLV) adding 0.1%.

The iShares Biotechnology ETF (IBB) fell 0.5%.

In corporate news, Marinus Pharmaceuticals MRNS shares gained 2.2% as it said Friday that it has completed enrollment in a phase 3 trial of oral ganaxolone for the treatment of seizures associated with tuberous sclerosis complex in children and adults.